BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership.
This milestone represents a new chapter for both BNP Paribas and Exane, thanks to the strong collaboration and long-standing commitments from the teams of both firms.
https://twitter.com/BNPParibasCIB/status/1414861326221025281
Leveraging Exane’s expertise in cash equities (execution and research) and derivatives, BNP Paribas will be able to provide a full suite of services on equities to Institutional investors and Corporates worldwide, positioning the bank as a leading provider in Global Equities.
Source: BNP Paribas
